Last reviewed · How we verify
Disease management of gastroesophageal reflux disease
Disease management of gastroesophageal reflux disease is a Small molecule drug developed by US Department of Veterans Affairs. It is currently in Phase 1 development.
At a glance
| Generic name | Disease management of gastroesophageal reflux disease |
|---|---|
| Sponsor | US Department of Veterans Affairs |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Disease management of gastroesophageal reflux disease CI brief — competitive landscape report
- Disease management of gastroesophageal reflux disease updates RSS · CI watch RSS
- US Department of Veterans Affairs portfolio CI
Frequently asked questions about Disease management of gastroesophageal reflux disease
What is Disease management of gastroesophageal reflux disease?
Disease management of gastroesophageal reflux disease is a Small molecule drug developed by US Department of Veterans Affairs.
Who makes Disease management of gastroesophageal reflux disease?
Disease management of gastroesophageal reflux disease is developed by US Department of Veterans Affairs (see full US Department of Veterans Affairs pipeline at /company/us-department-of-veterans-affairs).
What development phase is Disease management of gastroesophageal reflux disease in?
Disease management of gastroesophageal reflux disease is in Phase 1.